Brystana G. Kaufman, PhD, MSPH

Articles by Brystana G. Kaufman, PhD, MSPH

Prospective or Retrospective ACO Attribution Matters for Seriously Ill Patients

ByBrystana G. Kaufman, PhD, MSPH,William K. Bleser, PhD, MSPH,Robert Saunders, PhD,David Anderson, MSPPM,Courtney H. Van Houtven, PhD,David B. Muhlestein, PhD, JD,Jeffrey Clough, MD,Mark B. McClellan, MD, PhD

December 8th 2020

This study compared beneficiary characteristics and Medicare per capita expenditures among seriously ill Medicare accountable care organization (ACO) populations defined using prospective and retrospective claims-based attribution methods.

Latest Updated Articles

Prospective or Retrospective ACO Attribution Matters for Seriously Ill Patients
Published: December 8th 2020 | Updated:

Brystana G. Kaufman, PhD, MSPH

Articles by Brystana G. Kaufman, PhD, MSPH

Prospective or Retrospective ACO Attribution Matters for Seriously Ill Patients

Latest Updated Articles

Trending on AJMC

FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH

In Primary Care–Oncology Collaboration, the Baton Goes Both Ways

FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer

Trust and Transparency Key for Leveraging AI to Expand Access to Precision Oncology

Information and Integration Can Take Oncology Patients From Surviving to Thriving